Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine
S Shrestha, A Shrestha - The Lancet Global Health, 2024 - thelancet.com
More than two decades after the first introduction of pneumococcal conjugate vaccine (PCV),
the diseases caused by Streptococcal pneumoniae still remain an important cause of …
the diseases caused by Streptococcal pneumoniae still remain an important cause of …
Policy perspectives on the sustainable introduction of pneumococcal conjugate vaccines in middle-income countries
R Weeks, B Dhaliwal, J Huber, S Nabia, AF Al-Shaikh… - medRxiv, 2024 - medrxiv.org
Despite the well-documented life-saving potential of pneumococcal conjugate vaccines
(PCV) and global efforts to widen vaccine availability, access to PCV in middle-income …
(PCV) and global efforts to widen vaccine availability, access to PCV in middle-income …